查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386150

伴侶動物疫苗市場報告：2030 年趨勢、預測與競爭分析

Companion Animal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

伴侶動物疫苗趨勢和預測

預計到 2030 年，全球伴侶動物疫苗市場將達到 48 億美元，2024 年至 2030 年年複合成長率為 6.3%。該市場的主要促進因素是人們對寵物疫苗接種重要性的認知不斷提高、通用感染疾病病例不斷增加以及世界各地對養寵物的興趣日益濃厚。全球伴侶動物疫苗市場前景廣闊，醫院和診所市場以及研究機構市場充滿機會。

伴侶動物疫苗市場洞察

Lucintel 預測，由於飼主越來越意識到接種疫苗以保護寵物免受嚴重疾病的重要性，犬科動物仍將是最大的細分市場。

在這個市場中，醫院和診所預計將在預測期內實現最高成長。

由於寵物擁有量較高以及該地區人口對寵物疫苗接種重要性的認知不斷增強，北美可能仍然是最大的地區。

市場規模/估計：以金額估計伴侶動物疫苗的市場規模（十億美元）。

趨勢和預測分析：各個細分市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

細分分析：按產品類型、物種類型、最終用途和地區分類的伴侶動物疫苗市場規模（金額（十億美元））。

區域分析：北美、歐洲、亞太地區和世界其他地區、中東和非洲伴侶動物疫苗市場細分。

成長機會：伴侶動物疫苗市場成長機會依產品類型、動物種類、最終用途及地區進行分析。

策略分析：這包括併購、新產品開發以及伴侶動物疫苗市場的競爭形勢。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球伴侶動物疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球伴侶動物疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品類型分類的全球伴侶動物疫苗市場
    • 減毒變態
    • 組合型
    • 失活
    • 亞基
    • 類毒素
    • DNA
    • 重組
  • 按物種類型分類的全球伴侶動物疫苗市場
    • 犬科動物
    • 鳥類
    • 貓科動物
    • 馬
  • 全球伴侶動物疫苗市場（依最終用途）
    • 醫院和診所
    • 研究機構
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球伴侶動物疫苗市場區域分佈
  • 北美伴侶動物疫苗市場
  • 歐洲伴侶動物疫苗市場
  • 亞太地區伴侶動物疫苗市場
  • 其他地區伴侶動物疫苗市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球伴侶動物疫苗市場成長機會
    • 按物種類型分類的全球伴侶動物疫苗市場成長機會
    • 全球伴侶動物疫苗市場成長機會（依最終用途）
    • 全球伴侶動物疫苗市場成長機會（按地區）
  • 全球伴侶動物疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球伴侶動物疫苗市場的產能
    • 全球伴侶動物疫苗市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences
簡介目錄

Companion Animal Vaccine Trends and Forecast

The future of the global companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets. The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

A more than 150-page report is developed to help in your business decisions.

Companion Animal Vaccine by Segment

The study includes a forecast for the global companion animal vaccine by product type, species type, end use, and region.

Companion Animal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live
  • Conjugate
  • Inactivated
  • Subunit
  • Toxoid
  • DNA
  • Recombinant

Companion Animal Vaccine Market by Species Type [Shipment Analysis by Value from 2018 to 2030]:

  • Canine
  • Avian
  • Feline
  • Equine

Companion Animal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Research Institutes
  • Others

Companion Animal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Companion Animal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies companion animal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the companion animal vaccine companies profiled in this report include-

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences

Companion Animal Vaccine Market Insights

Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Within this market, hospital & clinic is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Features of the Global Companion Animal Vaccine Market

Market Size Estimates: Companion animal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Companion animal vaccine market size by product type, species type, end use, and region in terms of value ($B).

Regional Analysis: Companion animal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, species types, end uses, and regions for the companion animal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the companion animal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the companion animal vaccine market size?

Answer: The global companion animal vaccine market is expected to reach an estimated $4.8 billion by 2030.

Q.2 What is the growth forecast for companion animal vaccine market?

Answer: The global companion animal vaccine market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the companion animal vaccine market?

Answer: The major drivers for this market are rising awareness about importance of pet vaccination, growing cases of zoonotic diseases, and increasing interest for pet ownership in the world.

Q4. What are the major segments for companion animal vaccine market?

Answer: The future of the companion animal vaccine market looks promising with opportunities in the hospital & clinic and research institute markets.

Q5. Who are the key companion animal vaccine market companies?

Answer: Some of the key companion animal vaccine companies are as follows:

  • Elanco
  • Boehringer Ingelheim International
  • Intervet
  • Zoetis Services
  • Bioveta
  • Sanofi
  • Bayer
  • Heska
  • Virbac
  • Hester Biosciences

Q6. Which companion animal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that canine will remain the largest segment due to increasing awareness of the importance of this vaccination among dog owners for protecting their pets from serious diseases.

Q7. In companion animal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high pet ownership rates and increasing awareness of the importance of pet vaccination among population in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the companion animal vaccine market by product type (attenuated live, conjugate, inactivated, subunit, toxoid, DNA, and recombinant), species type (canine, avian, feline, and equine), end use (hospitals & clinics, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Companion Animal Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Companion Animal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Companion Animal Vaccine Market by Product Type
    • 3.3.1: Attenuated Live
    • 3.3.2: Conjugate
    • 3.3.3: Inactivated
    • 3.3.4: Subunit
    • 3.3.5: Toxoid
    • 3.3.6: DNA
    • 3.3.7: Recombinant
  • 3.4: Global Companion Animal Vaccine Market by Species Type
    • 3.4.1: Canine
    • 3.4.2: Avian
    • 3.4.3: Feline
    • 3.4.4: Equine
  • 3.5: Global Companion Animal Vaccine Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Research Institutes
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Companion Animal Vaccine Market by Region
  • 4.2: North American Companion Animal Vaccine Market
    • 4.2.1: North American Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.2.2: North American Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.3: European Companion Animal Vaccine Market
    • 4.3.1: European Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.3.2: European Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.4: APAC Companion Animal Vaccine Market
    • 4.4.1: APAC Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.4.2: APAC Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others
  • 4.5: ROW Companion Animal Vaccine Market
    • 4.5.1: ROW Companion Animal Vaccine Market by Species Type: Canine, Avian, Feline, and Equine
    • 4.5.2: ROW Companion Animal Vaccine Market by End Use: Hospitals & Clinics, Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Companion Animal Vaccine Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Companion Animal Vaccine Market by Species Type
    • 6.1.3: Growth Opportunities for the Global Companion Animal Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Companion Animal Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Companion Animal Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Companion Animal Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Companion Animal Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Elanco
  • 7.2: Boehringer Ingelheim International
  • 7.3: Intervet
  • 7.4: Zoetis Services
  • 7.5: Bioveta
  • 7.6: Sanofi
  • 7.7: Bayer
  • 7.8: Heska
  • 7.9: Virbac
  • 7.10: Hester Biosciences